366 related articles for article (PubMed ID: 37064609)
1. Engineering molecular nanoprobes to target early atherosclerosis: Precise diagnostic tools and promising therapeutic carriers.
Zan C; An J; Wu Z; Li S
Nanotheranostics; 2023; 7(3):327-344. PubMed ID: 37064609
[TBL] [Abstract][Full Text] [Related]
2. Dual-modality Imaging of Angiogenesis in Unstable Atherosclerotic Plaques with VEGFR2-Targeted Upconversion Nanoprobes in vivo.
Fang Y; Yang R; Hou Y; Wang Y; Yang N; Xu M; Li S; Gao S; Jiang M; Fan J; Hu Y; Xu Z; Gao L; Cao F
Mol Imaging Biol; 2022 Oct; 24(5):721-731. PubMed ID: 35604528
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in molecular imaging of atherosclerotic plaques and thrombosis.
Qiao R; Huang X; Qin Y; Li Y; Davis TP; Hagemeyer CE; Gao M
Nanoscale; 2020 Apr; 12(15):8040-8064. PubMed ID: 32239038
[TBL] [Abstract][Full Text] [Related]
4. Highly Bright AIE Nanoparticles by Regulating the Substituent of Rhodanine for Precise Early Detection of Atherosclerosis and Drug Screening.
Wang K; Gao H; Zhang Y; Yan H; Si J; Mi X; Xia S; Feng X; Liu D; Kong D; Wang T; Ding D
Adv Mater; 2022 Mar; 34(9):e2106994. PubMed ID: 34921573
[TBL] [Abstract][Full Text] [Related]
5. Molecular imaging of the extracellular matrix in the context of atherosclerosis.
Reimann C; Brangsch J; Colletini F; Walter T; Hamm B; Botnar RM; Makowski MR
Adv Drug Deliv Rev; 2017 Apr; 113():49-60. PubMed ID: 27639968
[TBL] [Abstract][Full Text] [Related]
6. Molecular Imaging of Inflammation in a Mouse Model of Atherosclerosis Using a Zirconium-89-Labeled Probe.
Ahmed M; Tegnebratt T; Tran TA; Lu L; Damberg P; Gisterå A; Tarnawski L; Bone D; Hedin U; Eriksson P; Holmin S; Gustafsson B; Caidahl K
Int J Nanomedicine; 2020; 15():6137-6152. PubMed ID: 32884268
[TBL] [Abstract][Full Text] [Related]
7. Improved in vivo detection of atherosclerotic plaques with a tissue factor-targeting magnetic nanoprobe.
Wei Q; Wang J; Shi W; Zhang B; Jiang H; Du M; Mei H; Hu Y
Acta Biomater; 2019 May; 90():324-336. PubMed ID: 30954623
[TBL] [Abstract][Full Text] [Related]
8. Sphingomyelinase-responsive nanomicelles for targeting atherosclerosis.
Muñoz-Hernando M; Nogales P; Fernández-Barahona I; Ruiz-Cabello J; Bentzon JF; Herranz F
Nanoscale; 2024 Mar; 16(13):6477-6487. PubMed ID: 38426659
[TBL] [Abstract][Full Text] [Related]
9. In vivo near infrared fluorescence (NIRF) intravascular molecular imaging of inflammatory plaque, a multimodal approach to imaging of atherosclerosis.
Calfon MA; Rosenthal A; Mallas G; Mauskapf A; Nudelman RN; Ntziachristos V; Jaffer FA
J Vis Exp; 2011 Aug; (54):. PubMed ID: 21847078
[TBL] [Abstract][Full Text] [Related]
10. Targeting P-selectin by gallium-68-labeled fucoidan positron emission tomography for noninvasive characterization of vulnerable plaques: correlation with in vivo 17.6T MRI.
Li X; Bauer W; Israel I; Kreissl MC; Weirather J; Richter D; Bauer E; Herold V; Jakob P; Buck A; Frantz S; Samnick S
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1661-7. PubMed ID: 24903095
[TBL] [Abstract][Full Text] [Related]
11. Nanobody-Facilitated Multiparametric PET/MRI Phenotyping of Atherosclerosis.
Senders ML; Hernot S; Carlucci G; van de Voort JC; Fay F; Calcagno C; Tang J; Alaarg A; Zhao Y; Ishino S; Palmisano A; Boeykens G; Meerwaldt AE; Sanchez-Gaytan BL; Baxter S; Zendman L; Lobatto ME; Karakatsanis NA; Robson PM; Broisat A; Raes G; Lewis JS; Tsimikas S; Reiner T; Fayad ZA; Devoogdt N; Mulder WJM; Pérez-Medina C
JACC Cardiovasc Imaging; 2019 Oct; 12(10):2015-2026. PubMed ID: 30343086
[TBL] [Abstract][Full Text] [Related]
12. Nanoprobes for Computed Tomography and Magnetic Resonance Imaging in Atherosclerosis Research.
Ghaghada KB; Bhavane R; Badachhape A; Tanifum E; Annapragada A
Methods Mol Biol; 2022; 2419():809-823. PubMed ID: 35238003
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Managing Atherosclerosis via Nanomedicine.
Chan CKW; Zhang L; Cheng CK; Yang H; Huang Y; Tian XY; Choi CHJ
Small; 2018 Jan; 14(4):. PubMed ID: 29239134
[TBL] [Abstract][Full Text] [Related]
14. Multimodality Molecular Imaging of Cardiovascular Disease Based on Nanoprobes.
Tu Y; Sun Y; Fan Y; Cheng Z; Yu B
Cell Physiol Biochem; 2018; 48(4):1401-1415. PubMed ID: 30064129
[TBL] [Abstract][Full Text] [Related]
15. Multi-Modality Imaging of Atheromatous Plaques in Peripheral Arterial Disease: Integrating Molecular and Imaging Markers.
Wang X; Nai YH; Gan J; Lian CPL; Ryan FK; Tan FSL; Chan DYS; Ng JJ; Lo ZJ; Chong TT; Hausenloy DJ
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446302
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of Atherosclerotic Disease: Advancing Plaque Assessment from Anatomy to Pathophysiology.
Evans NR; Tarkin JM; Chowdhury MM; Warburton EA; Rudd JH
Curr Atheroscler Rep; 2016 Jun; 18(6):30. PubMed ID: 27108163
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo targeting ability between cRGD and collagen-targeting peptide conjugated nano-carriers for atherosclerosis.
Kim M; Sahu A; Kim GB; Nam GH; Um W; Shin SJ; Jeong YY; Kim IS; Kim K; Kwon IC; Tae G
J Control Release; 2018 Jan; 269():337-346. PubMed ID: 29175140
[TBL] [Abstract][Full Text] [Related]
18. Non-invasive molecular imaging of vulnerable atherosclerotic plaques.
Magnoni M; Ammirati E; Camici PG
J Cardiol; 2015 Apr; 65(4):261-9. PubMed ID: 25702846
[TBL] [Abstract][Full Text] [Related]
19. Recent advances in visualizing vulnerable plaque: focus on noninvasive molecular imaging.
Bala G; Cosyns B
Curr Cardiol Rep; 2014 Sep; 16(9):520. PubMed ID: 25059464
[TBL] [Abstract][Full Text] [Related]
20. Molecular magnetic resonance imaging of atherosclerotic vessel wall disease.
Nörenberg D; Ebersberger HU; Diederichs G; Hamm B; Botnar RM; Makowski MR
Eur Radiol; 2016 Mar; 26(3):910-20. PubMed ID: 26139316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
